| View |
|
DRP-9975-14
|
Cefuroxime (as axetil)
|
Roxurix
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
01 July 2026
|
| View |
|
HRP-417-07
|
Tretinoin + Hydroquinone
|
iPLEDGE SKIN ADVANCE REJUV
|
10 mg/2g per 100 mL (0.01%/2%)
|
Topical Solution
|
Exfoliant / Anti-Acne / Depigmenting
|
Refinette Cosmetic Manufacturing Corporation
|
Philippines
|
CLIDP Conversion
|
24 September 2024
|
15 March 2026
|
| View |
|
DRP-9885-15
|
Ascorbic Acid + Zinc
|
Luzinc
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
25 January 2026
|
| View |
|
DRP-9896-07
|
Budesonide
|
Budmed
|
250 mcg/ mL (500 mcg/ 2mL)
|
Suspension for Nebulization
|
Corticosteroid
|
AXA Parenterals Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
24 June 2025
|
| View |
|
HRP-268-04
|
Isopropyl Alcohol
|
Alcogen
|
70% (v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
13 September 2024
|
28 August 2029
|
| View |
|
DRP-9885-16
|
Ascorbic Acid + Zinc
|
X-Cee Plus
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
27 September 2024
|
25 January 2026
|
| View |
|
DRP-13970
|
Bisacodyl
|
Vesilac
|
10 mg
|
Suppository
|
Laxative
|
Y.S.P Industries (M) Sdn. Bhd
|
Malaysia
|
Renewal
|
06 November 2023
|
03 February 2029
|
| View |
|
DRP-15709
|
Ketoconazole + Clobetasol propionate + Neomycin
|
Novaderm
|
10 mg/250 mcg/5000 IU per gram
|
Topical Cream
|
Antifungal/Antipruritic/Antibacterial
|
S Kant Healthcare Ltd.
|
India
|
Initial
|
30 August 2024
|
30 August 2029
|
| View |
|
DRP-15705
|
Vildagliptin
|
Glipinova
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors
|
Saludcare (I) Pvt. Ltd.
|
India
|
Initial
|
29 August 2024
|
29 August 2029
|
| View |
|
DRP-15714
|
Atorvastatin (as calcium)
|
Medivazt-20
|
20 mg
|
Film-Coated Tablet
|
HMG CoA reductase inhibitor
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
Initial
|
06 September 2024
|
06 September 2029
|
| View |
|
DRP-8994-14
|
Gliclazide
|
Kodizide
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
14 August 2025
|
| View |
|
DRP-8994-10
|
Gliclazide
|
GliXa
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
02 November 2024
|
14 August 2030
|
| View |
|
DRP-8994-09
|
Gliclazide
|
Gliget MR
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
09 November 2024
|
14 August 2030
|
| View |
|
DRP-15831
|
Levodopa + Carbidopa (as monohydrate) + Entacapone
|
Lecarpone
|
50 mg/12.5 mg/200 mg
|
Film Coated Tablet
|
Anti-Parkinson Drug (Dopaminergic Agent)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
24 September 2024
|
24 September 2029
|
| View |
|
DRP-15868
|
Azithromycin (as dihydrate)
|
Kotrazith
|
500 mg
|
Lyophilized Powder for Injection for I.V.
Infusion
|
Antibacterial (Macrolide)
|
Kotra Pharma (M) SDN. BHD
|
Malaysia
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15845
|
Apixaban
|
Axiban
|
5 mg
|
Tablet
|
Antithrombotic Agent (Direct Factor Xa Inhibitor)
|
Globela Pharma Private Limited
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DRP-15846
|
Potassium Citrate
|
Noston
|
1.620 g
|
Extended-Release
|
Antiurolithic
|
Nucare Labs LLP
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DR-XY49230
|
Ampicillin (as sodium) + Sulbactam (as sodium) + Sulbactam (as sodium)
|
Sitampex
|
1 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., LTD.
|
China
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15857
|
Quetiapine (as fumarate)
|
Mediquet 50
|
50 mg
|
Extended-Release Tablet
|
Antipsychotic (Diazepines, Oxazipines,
and Oxepines)
|
Cubit Lifesciences LLP
|
India
|
Initial
|
24 September 2024
|
24 September 2029
|
| View |
|
DRP-15873
|
Quetiapine (as fumarate)
|
Mediquet 200
|
200 mg
|
Extended-Release Tablet
|
Antipsychotic (Diazepines, Oxazipines, Thiazepines,
and Oxepines)
|
Cubit Lifesciences LLP
|
India
|
Initial
|
25 September 2024
|
25 September 2029
|